Brenntag North America

Brenntag is the global market leader in full-line range of chemical and ingredient products and value-added services. As one of the four geographically structured segments of the Brenntag Group, Brenntag North America operates over 180 locations across the United States and Canada with more than 4,600 employees through.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

HOW SMALL CHEMICAL COMPANY LEADERS ARE DEALING WITH THE CORONAVIRUS

C&EN | March 17, 2020

news image

As measures to contain the coronavirus—SARS-CoV-2—sweep across the US, the heads of privately owned chemical and instrument companies find themselves in uncharted territory trying to keep their companies going and their employees safe. C&EN reached out to CEOs of several such firms to learn what they are doing to keep business moving forward. We heard stories about setbacks, as expected supplies didn’t come through, but also small triumphs, as needed safety equipment was fi...

Read More

CHEMICAL MANAGEMENT

PARKLAND RAMPS-UP PROCESSING OPERATIONS AT THE BURNABY REFINERY

Parkland Corporation | December 15, 2021

news image

Parkland Corporation announced that following the restart of the Trans Mountain Pipeline on December 5, 2021, it is ramping-up processing operations at the Burnaby Refinery. The Pipeline is the primary source of crude oil feedstock to the refinery. "Having maintained the refinery in ready-mode and following delivery of sufficient, consistent quality crude oil feedstocks via the pipeline, we are ramping-up processing operations. I am proud of the Parkland...

Read More

ST. LUKE'S CONTRIBUTES TO RESEARCH ON MONOCLONAL ANTIBODIES MADE FAMOUS BY PRESIDENT TRUMP'S TREATMENT

Prnewswire | October 09, 2020

news image

Patients who recovered from COVID-19 at St. Luke's University Health Network have donated their antibody-rich blood to medical science in hopes of helping to find an effective treatment or cure to the novel coronavirus that has killed nearly 200,000 Americans. The "convalescent plasma" was separated from the survivors' blood and is being studied as part of a research project labeled AR-701, sponsored by Aridis Pharmaceuticals, a biopharmaceutical firm in San Jose, Ca., th...

Read More

CHEMICAL MANAGEMENT

HUNTSMAN COMPLETES THE ACQUISITION OF GABRIEL PERFORMANCE PRODUCTS, FURTHER EXPANDING ITS SPECIALTY CHEMICALS PORTFOLIO

Huntsman | January 20, 2021

news image

Huntsman Corporation (NYSE: HUN) today announced it completed the acquisition of Gabriel Performance Products (Gabriel), a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets, from Audax Private Equity. Huntsman paid $250 million, subject to customary closing adjustments, in an all-cash transaction funded from available liquidity. Gabriel had 2019 revenues of approximately $106 millio...

Read More
news image

HOW SMALL CHEMICAL COMPANY LEADERS ARE DEALING WITH THE CORONAVIRUS

C&EN | March 17, 2020

As measures to contain the coronavirus—SARS-CoV-2—sweep across the US, the heads of privately owned chemical and instrument companies find themselves in uncharted territory trying to keep their companies going and their employees safe. C&EN reached out to CEOs of several such firms to learn what they are doing to keep business moving forward. We heard stories about setbacks, as expected supplies didn’t come through, but also small triumphs, as needed safety equipment was fi...

Read More
news image

CHEMICAL MANAGEMENT

PARKLAND RAMPS-UP PROCESSING OPERATIONS AT THE BURNABY REFINERY

Parkland Corporation | December 15, 2021

Parkland Corporation announced that following the restart of the Trans Mountain Pipeline on December 5, 2021, it is ramping-up processing operations at the Burnaby Refinery. The Pipeline is the primary source of crude oil feedstock to the refinery. "Having maintained the refinery in ready-mode and following delivery of sufficient, consistent quality crude oil feedstocks via the pipeline, we are ramping-up processing operations. I am proud of the Parkland...

Read More
news image

ST. LUKE'S CONTRIBUTES TO RESEARCH ON MONOCLONAL ANTIBODIES MADE FAMOUS BY PRESIDENT TRUMP'S TREATMENT

Prnewswire | October 09, 2020

Patients who recovered from COVID-19 at St. Luke's University Health Network have donated their antibody-rich blood to medical science in hopes of helping to find an effective treatment or cure to the novel coronavirus that has killed nearly 200,000 Americans. The "convalescent plasma" was separated from the survivors' blood and is being studied as part of a research project labeled AR-701, sponsored by Aridis Pharmaceuticals, a biopharmaceutical firm in San Jose, Ca., th...

Read More
news image

CHEMICAL MANAGEMENT

HUNTSMAN COMPLETES THE ACQUISITION OF GABRIEL PERFORMANCE PRODUCTS, FURTHER EXPANDING ITS SPECIALTY CHEMICALS PORTFOLIO

Huntsman | January 20, 2021

Huntsman Corporation (NYSE: HUN) today announced it completed the acquisition of Gabriel Performance Products (Gabriel), a North American specialty chemical manufacturer of specialty additives and epoxy curing agents for the coatings, adhesives, sealants and composite end-markets, from Audax Private Equity. Huntsman paid $250 million, subject to customary closing adjustments, in an all-cash transaction funded from available liquidity. Gabriel had 2019 revenues of approximately $106 millio...

Read More